Skip to main content
Erschienen in: Lung 4/2016

23.04.2016

Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection

verfasst von: Nicole M. Geissen, Robert Medairos, Edgar Davila, Sanjib Basu, William H. Warren, Gary W. Chmielewski, Michael J. Liptay, Andrew T. Arndt, Christopher W. Seder

Erschienen in: Lung | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pulmonary lobectomy with en bloc chest wall resection is a common strategy for treating lung cancers invading the chest wall. We hypothesized a direct relationship exists between number of ribs resected and postoperative respiratory complications.

Methods

An institutional database was queried for patients with non-small cell lung cancer that underwent lobectomy with en bloc chest wall resection between 2003 and 2014. Propensity matching was used to identify a cohort of patients who underwent lobectomy via thoracotomy without chest wall resection. Patients were propensity matched on age, gender, smoking history, FEV1, and DLCO. The relationship between number of ribs resected and postoperative respiratory complications (bronchoscopy, re-intubation, pneumonia, or tracheostomy) was examined.

Results

Sixty-eight patients (34 chest wall resections; 34 without chest wall resection) were divided into 3 cohorts: cohort A = 0 ribs resected (n = 34), cohort B = 1–3 ribs resected (n = 24), and cohort C = 4–6 ribs resected (n = 10). Patient demographics were similar between cohorts. The 90-day mortality rate was 2.9 % (2/68) and did not vary between cohorts. On multivariate analysis, having 1–3 ribs resected (OR 19.29, 95 % CI (1.33, 280.72); p = 0.03), 4–6 ribs resected [OR 26.66, (1.48, 481.86); p = 0.03), and a lower DLCO (OR 0.91, (0.84, 0.99); p = 0.02) were associated with postoperative respiratory complications.

Conclusions

In patients undergoing lobectomy with en bloc chest wall resection for non-small cell lung cancer, the number of ribs resected is directly associated with incidence of postoperative respiratory complications.
Literatur
1.
Zurück zum Zitat Dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32:605–644CrossRefPubMed Dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32:605–644CrossRefPubMed
2.
Zurück zum Zitat Kubuschok B, Passlick B, Izbicki JR et al (1999) Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin 17:19–24 Kubuschok B, Passlick B, Izbicki JR et al (1999) Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin 17:19–24
3.
Zurück zum Zitat Chapelier A, Fadel E, Macchiarini P et al (2000) Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall. Eur J Cardiothorac Surg 18:513–518CrossRefPubMed Chapelier A, Fadel E, Macchiarini P et al (2000) Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall. Eur J Cardiothorac Surg 18:513–518CrossRefPubMed
4.
Zurück zum Zitat Doddoli C, D’Journo B, Pimpec-Barthes FL et al (2005) Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg 80:2032–2040CrossRefPubMed Doddoli C, D’Journo B, Pimpec-Barthes FL et al (2005) Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg 80:2032–2040CrossRefPubMed
5.
Zurück zum Zitat Stoelben E, Ludwig C (2009) Chest wall resection for lung cancer: indications and techniques. Eur J Cardiothorac Surg 35:450–456CrossRefPubMed Stoelben E, Ludwig C (2009) Chest wall resection for lung cancer: indications and techniques. Eur J Cardiothorac Surg 35:450–456CrossRefPubMed
6.
Zurück zum Zitat Cardillo G, Spaggiari L, Galetta D et al (2013) Pneumonectomy with en bloc chest wall resection: is it worthwhile? Report on 34 patients from two institutions. Interact CardioVasc Thorac Surg 17:54–58CrossRefPubMedPubMedCentral Cardillo G, Spaggiari L, Galetta D et al (2013) Pneumonectomy with en bloc chest wall resection: is it worthwhile? Report on 34 patients from two institutions. Interact CardioVasc Thorac Surg 17:54–58CrossRefPubMedPubMedCentral
7.
8.
Zurück zum Zitat Akay H, Cangir AK, Kutlay H et al (2002) Surgical treatment of peripheral lung cancer adherent to the parietal pleura. Eur J Cardiothorac Surg 22:615–620CrossRefPubMed Akay H, Cangir AK, Kutlay H et al (2002) Surgical treatment of peripheral lung cancer adherent to the parietal pleura. Eur J Cardiothorac Surg 22:615–620CrossRefPubMed
9.
Zurück zum Zitat Coleman FP (1947) Primary carcinoma of lung with invasion of ribs: pneumonectomy and simultaneous block resection of chest wall. Ann Surg 126:156–158CrossRefPubMedPubMedCentral Coleman FP (1947) Primary carcinoma of lung with invasion of ribs: pneumonectomy and simultaneous block resection of chest wall. Ann Surg 126:156–158CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Allen MS, Mathisen DJ, Grillo HC et al (1991) Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg 51:948–951CrossRefPubMed Allen MS, Mathisen DJ, Grillo HC et al (1991) Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg 51:948–951CrossRefPubMed
11.
Zurück zum Zitat Downey RJ, Martini N, Rusch VW et al (1999) Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg 68:188–193CrossRefPubMed Downey RJ, Martini N, Rusch VW et al (1999) Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg 68:188–193CrossRefPubMed
12.
Zurück zum Zitat Magdeleinat P, Alifano M, Benbrahem C et al (2001) Surgical treatment of lung cancer invading the chest wall: results and prognostic factors. Ann Thorac Surg 71:1094–1099CrossRefPubMed Magdeleinat P, Alifano M, Benbrahem C et al (2001) Surgical treatment of lung cancer invading the chest wall: results and prognostic factors. Ann Thorac Surg 71:1094–1099CrossRefPubMed
13.
Zurück zum Zitat Matsuoka H, Nishio W, Okada M et al (2004) Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg 26:1200–1204CrossRefPubMed Matsuoka H, Nishio W, Okada M et al (2004) Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg 26:1200–1204CrossRefPubMed
14.
Zurück zum Zitat Burkhart HM, Allen MS, Nichols FC et al (2002) Results of en bloc resection for bronchogenic carcinoma with chest wall invasion. J Thorac Cardiovasc Surg 123:670–675CrossRefPubMed Burkhart HM, Allen MS, Nichols FC et al (2002) Results of en bloc resection for bronchogenic carcinoma with chest wall invasion. J Thorac Cardiovasc Surg 123:670–675CrossRefPubMed
15.
Zurück zum Zitat Facciolo F, Cardillo G, Lopergolo M et al (2001) Chest wall invasion in non-small cell lung carcinoma: a rational for en bloc resection. J Thorac Cardiovasc Surg 121:645–656CrossRef Facciolo F, Cardillo G, Lopergolo M et al (2001) Chest wall invasion in non-small cell lung carcinoma: a rational for en bloc resection. J Thorac Cardiovasc Surg 121:645–656CrossRef
16.
Zurück zum Zitat Riquet M, Arame M, Le Pimpec Barthes F (2010) Non-small cell lung cancer invading the chest wall. Thorac Surg Clin 20:519–527CrossRefPubMed Riquet M, Arame M, Le Pimpec Barthes F (2010) Non-small cell lung cancer invading the chest wall. Thorac Surg Clin 20:519–527CrossRefPubMed
17.
Zurück zum Zitat McCaughan BC, Martini N, Bains MS et al (1985) Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications. J Thorac Cardiovasc Surg 89:836–841PubMed McCaughan BC, Martini N, Bains MS et al (1985) Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications. J Thorac Cardiovasc Surg 89:836–841PubMed
Metadaten
Titel
Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection
verfasst von
Nicole M. Geissen
Robert Medairos
Edgar Davila
Sanjib Basu
William H. Warren
Gary W. Chmielewski
Michael J. Liptay
Andrew T. Arndt
Christopher W. Seder
Publikationsdatum
23.04.2016
Verlag
Springer US
Erschienen in
Lung / Ausgabe 4/2016
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9882-3

Weitere Artikel der Ausgabe 4/2016

Lung 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.